课题基金 / 基金详情

Natural product Synthesis by Rh Catalyzed {2+2+2} Cycloadditions

Natural product Synthesis by Rh Catalyzed {2+2+2} Cycloadditions
Rh 催化 {2 2 2} 环加成合成天然产物
批准号:
8137148
负责人:
Derek M. Dalton
金额:
$3.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2013-08-31

项目摘要

项目成果

Derek M. Dalton的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The broad, long-term objective of this project in synthetic organic methodology is to develop a rapid, efficient, and enantioselective means of assembling biologically relevant indolizidine and quinolizidine containing natural products. Specifically the proposed research aims to extend the rhodium catalyzed [2+2+2] cycloaddition of alkenyl isocyanates with exogenous alkynes to include functionalized, highly reactive cycloalkynes. We plan to apply the newly expanded methodology to the synthesis of complex natural products: acosmine and dasycarpumine. These diazadamantane alkaloids have been used as folk medicines for the treatment of a number of ailments including syphilis and malaria. Additionally, acosmine has been shown to be effective in the treatment of diabetes in rats by increasing insulin secretion. The reasons we have chosen to pursue the synthesis of these alkaloids are twofold. First, the diazadamantane skeleton poses unique synthetic challenges, and second, the application of our methodology to the synthesis of these compounds would highlight its utility while expanding its scope beyond its current state. Ir all, the synthesis of these compounds wou|d be of benefit to the development of new drugs that could be effective in the treatment of diabetes, syphilis, and malaria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Natural product Synthesis by Rh Catalyzed {2+2+2} Cycloadditions
  • 批准号:
    8324568
  • 项目类别:
  • 资助金额:
    $2.52万
  • 财政年份:
    2009
  • 负责人:
    Derek M. Dalton
  • 依托单位:
Natural product Synthesis by Rh Catalyzed {2+2+2} Cycloadditions
  • 批准号:
    7920959
  • 项目类别:
  • 资助金额:
    $3.0万
  • 财政年份:
    2009
  • 负责人:
    Derek M. Dalton
  • 依托单位:
海外基金